489 related articles for article (PubMed ID: 26500646)
1. Radio-Immunotherapy-Induced Immunogenic Cancer Cells as Basis for Induction of Systemic Anti-Tumor Immune Responses - Pre-Clinical Evidence and Ongoing Clinical Applications.
Derer A; Deloch L; Rubner Y; Fietkau R; Frey B; Gaipl US
Front Immunol; 2015; 6():505. PubMed ID: 26500646
[TBL] [Abstract][Full Text] [Related]
2. Induction of abscopal anti-tumor immunity and immunogenic tumor cell death by ionizing irradiation - implications for cancer therapies.
Frey B; Rubner Y; Wunderlich R; Weiss EM; Pockley AG; Fietkau R; Gaipl US
Curr Med Chem; 2012; 19(12):1751-64. PubMed ID: 22414083
[TBL] [Abstract][Full Text] [Related]
3. [Immunotherapy and radiotherapy].
Bockel S; Antoni D; Deutsch É; Mornex F
Cancer Radiother; 2017 May; 21(3):244-255. PubMed ID: 28522277
[TBL] [Abstract][Full Text] [Related]
4. Immune checkpoint inhibitors with radiotherapy and locoregional treatment: synergism and potential clinical implications.
Esposito A; Criscitiello C; Curigliano G
Curr Opin Oncol; 2015 Nov; 27(6):445-51. PubMed ID: 26447875
[TBL] [Abstract][Full Text] [Related]
5. Radiation effects on antitumor immune responses: current perspectives and challenges.
Walle T; Martinez Monge R; Cerwenka A; Ajona D; Melero I; Lecanda F
Ther Adv Med Oncol; 2018; 10():1758834017742575. PubMed ID: 29383033
[TBL] [Abstract][Full Text] [Related]
6. How does ionizing irradiation contribute to the induction of anti-tumor immunity?
Rubner Y; Wunderlich R; Rühle PF; Kulzer L; Werthmöller N; Frey B; Weiss EM; Keilholz L; Fietkau R; Gaipl US
Front Oncol; 2012; 2():75. PubMed ID: 22848871
[TBL] [Abstract][Full Text] [Related]
7. Barriers to Radiation-Induced
Wennerberg E; Lhuillier C; Vanpouille-Box C; Pilones KA; García-Martínez E; Rudqvist NP; Formenti SC; Demaria S
Front Immunol; 2017; 8():229. PubMed ID: 28348554
[TBL] [Abstract][Full Text] [Related]
8. Immunomodulation by ionizing radiation-impact for design of radio-immunotherapies and for treatment of inflammatory diseases.
Frey B; Rückert M; Deloch L; Rühle PF; Derer A; Fietkau R; Gaipl US
Immunol Rev; 2017 Nov; 280(1):231-248. PubMed ID: 29027224
[TBL] [Abstract][Full Text] [Related]
9. Nanotechnology-enhanced radiotherapy and the abscopal effect: Current status and challenges of nanomaterial-based radio-immunotherapy.
Viswanath D; Park J; Misra R; Pizzuti VJ; Shin SH; Doh J; Won YY
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2024; 16(1):e1924. PubMed ID: 37632203
[TBL] [Abstract][Full Text] [Related]
10. Combining radiation therapy and cancer immune therapies: From preclinical findings to clinical applications.
Bockel S; Durand B; Deutsch E
Cancer Radiother; 2018 Oct; 22(6-7):567-580. PubMed ID: 30197026
[TBL] [Abstract][Full Text] [Related]
11. Abscopal effect of radiotherapy combined with immune checkpoint inhibitors.
Liu Y; Dong Y; Kong L; Shi F; Zhu H; Yu J
J Hematol Oncol; 2018 Aug; 11(1):104. PubMed ID: 30115069
[TBL] [Abstract][Full Text] [Related]
12. Short review of potential synergies of immune checkpoint inhibition and radiotherapy with a focus on Hodgkin lymphoma: radio-immunotherapy opens new doors.
Baues C; Trommer-Nestler M; Jablonska K; Bröckelmann PJ; Schlaak M; von Bergwelt-Baildon M; Engert A; Semrau R; Marnitz S; Theurich S
Immunotherapy; 2017 Mar; 9(5):423-433. PubMed ID: 28357914
[TBL] [Abstract][Full Text] [Related]
13. Radiotherapy-Mediated Immunomodulation and Anti-Tumor Abscopal Effect Combining Immune Checkpoint Blockade.
Zhao X; Shao C
Cancers (Basel); 2020 Sep; 12(10):. PubMed ID: 32992835
[TBL] [Abstract][Full Text] [Related]
14. The Potentiation of Anti-Tumor Immunity by Tumor Abolition with Alpha Particles, Protons, or Carbon Ion Radiation and Its Enforcement by Combination with Immunoadjuvants or Inhibitors of Immune Suppressor Cells and Checkpoint Molecules.
Keisari Y; Kelson I
Cells; 2021 Jan; 10(2):. PubMed ID: 33503958
[TBL] [Abstract][Full Text] [Related]
15. The Abscopal Effect in the Era of Cancer Immunotherapy: a Spontaneous Synergism Boosting Anti-tumor Immunity?
Hlavata Z; Solinas C; De Silva P; Porcu M; Saba L; Willard-Gallo K; Scartozzi M
Target Oncol; 2018 Apr; 13(2):113-123. PubMed ID: 29470785
[TBL] [Abstract][Full Text] [Related]
16. Combination of radiotherapy and immune checkpoint inhibitors.
Pilones KA; Vanpouille-Box C; Demaria S
Semin Radiat Oncol; 2015 Jan; 25(1):28-33. PubMed ID: 25481263
[TBL] [Abstract][Full Text] [Related]
17. Combinations of Radiotherapy with Vaccination and Immune Checkpoint Inhibition Differently Affect Primary and Abscopal Tumor Growth and the Tumor Microenvironment.
Rückert M; Deloch L; Frey B; Schlücker E; Fietkau R; Gaipl US
Cancers (Basel); 2021 Feb; 13(4):. PubMed ID: 33572437
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic uses of anti-PD-1 and anti-PD-L1 antibodies.
Philips GK; Atkins M
Int Immunol; 2015 Jan; 27(1):39-46. PubMed ID: 25323844
[TBL] [Abstract][Full Text] [Related]
19. Antitumor immune responses induced by ionizing irradiation and further immune stimulation.
Frey B; Rubner Y; Kulzer L; Werthmöller N; Weiss EM; Fietkau R; Gaipl US
Cancer Immunol Immunother; 2014 Jan; 63(1):29-36. PubMed ID: 24052136
[TBL] [Abstract][Full Text] [Related]
20. Modern Radiotherapy Concepts and the Impact of Radiation on Immune Activation.
Deloch L; Derer A; Hartmann J; Frey B; Fietkau R; Gaipl US
Front Oncol; 2016; 6():141. PubMed ID: 27379203
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
